The Effect of Pharmacist Intervention on Blood Pressure Control

Hypertension Clinical Trial

— AFenPA  

Official title:

Pharmacist Intervention Effect on the Medication Adherence and Blood Pressure Control in Treated Patients

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01233193
• Other study ID #: DMM01-FAR-10
• Status: Active, not recruiting
• Phase: N/A
• First received: October 29, 2010
• Last updated: May 5, 2016
• Start date: February 2010
• Est. completion date: September 2011

Study information

• Verified date: February 2010
• Source: Universidad de Granada
• Contact: n/a
• Is FDA regulated: No
• Health authority: Spain: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to test if a Pharmacist Intervention Program with home blood pressure monitoring (HBPM) improves or controls pharmacological adherence and blood pressure levels in hypertensive patients under pharmacological treatment, compared to those who receive usual care in a community pharmacy setting.

Description:

Hypertension is a major health concern worldwide due to its deleterious impact on the population in terms of excessive morbidity and mortality, especially when there is insufficient hypertension control and prevention at the community level.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 140
• Est. completion date: September 2011
• Est. primary completion date: September 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients of both genders between the ages of 18 and 80 years, who access the pharmacy to fill their own prescription for hypertension.

Exclusion criteria:

• Patient living with an other Hypertensive patient treated with the same medications

• Pregnant women

• Hypertensive patients with levels of systolic/diastolic blood pressure = 180mmHg/110mmHg

• Patient with secondary hypertension, kidney or liver failure

• Patients already included in a care program for hypertensive patients

• Patients with a new treatment for hypertension (less than 1 month)

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Hypertension

Intervention

Behavioral:
• Health education, Home blood pressure monitoring
Health education (on hypertension, smoking, healthy diet, obesity, physical inactivity and adherence to antihypertensive medications and home blood pressure monitoring) . The patient will be referred to physician when needed. The patient will be followed up during 6 months.

Locations

Country	Name	City	State
Spain	Community Pharmacies	Granada	Andalucia
Spain	Community Pharmacies	Jaén	Andalucia

Sponsors (1)

Lead Sponsor	Collaborator
Universidad de Granada

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	blood pressure control	Percentage of patients with controlled hypertension	At 6 months	No
Secondary	Adherence	Percentage of adherent patients after 6 months within the trial	At 6 months	No